The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

Patients with type 2 diabetes who switched to tirzepatide rather than escalating their dulaglutide dosage had greater weight ...

Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP-1 medications ...

In one of the first real-world studies, Tirzepatide shows impressive weight loss results for people without diabetes—shedding nearly 13% of body weight in just six months. Study: Real-world use ...

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with ...

The drug tirzepatide improved kidney function and ... tirzepatide’s impact on kidney and cardiovascular outcomes in people with obesity, chronic kidney disease and HFpEF, a triad of conditions ...